Published in Anesth Analg on February 01, 1996
General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci (1999) 2.43
Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. Biophys J (2006) 1.19
Partitioning of anesthetics into a lipid bilayer and their interaction with membrane-bound peptide bundles. Biophys J (2006) 1.03
Membrane structural perturbations caused by anesthetics and nonimmobilizers: a molecular dynamics investigation. Biophys J (2001) 0.92
Anaesthetic mechanisms: update on the challenge of unravelling the mystery of anaesthesia. Eur J Anaesthesiol (2009) 0.87
Isoflurane impairs odour discrimination learning in rats: differential effects on short- and long-term memory. Br J Anaesth (2012) 0.78
Distinctive recruitment of endogenous sleep-promoting neurons by volatile anesthetics and a nonimmobilizer. Anesthesiology (2014) 0.77
Inhaled anesthetics in horses. Vet Clin North Am Equine Pract (2013) 0.76
HCN1 Channels Contribute to the Effects of Amnesia and Hypnosis but not Immobility of Volatile Anesthetics. Anesth Analg (2015) 0.75
Emulsified isoflurane combined with therapeutic hypothermia improves survival and neurological outcomes in a rat model of cardiac arrest. Exp Ther Med (2017) 0.75
Modulation of the membrane dipole potential: a prospective mechanism to differentiate anaesthetic/non-anaesthetic activity and a tool to assess susceptibility. J Lipid Res (2017) 0.75
Comparing the costs of inhaled anesthetics. Anesthesiology (1993) 4.39
Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg (1994) 4.12
Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology (1966) 2.34
Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology (1994) 2.30
Toxicity of compound A in rats. Effect of increasing duration of administration. Anesthesiology (1994) 2.12
Transient radicular pain following spinal anesthesia: review of the literature and report of a case involving 2% lidocaine. Int J Obstet Anesth (1996) 2.01
Isoflurane: a review. Anesthesiology (1981) 2.00
Determination and applications of MAC. Anesthesiology (1980) 1.83
Kinetics and potency of desflurance (I-653) in volunteers. Anesth Analg (1990) 1.82
Subanesthetic concentrations of desflurane and propofol suppress recall of emotionally charged information. Anesth Analg (1995) 1.75
Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme. Anesth Analg (1995) 1.74
Anesthesia by n-alkanes not consistent with the Meyer-Overton hypothesis: determinations of the solubilities of alkanes in saline and various lipids. Anesth Analg (1993) 1.70
Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg (1997) 1.66
Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg (1991) 1.63
Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg (1997) 1.53
Elderly, conscious patients have an accentuated hypotensive response to nitroglycerin. Anesthesiology (1992) 1.53
Molecular properties of the "ideal" inhaled anesthetic: studies of fluorinated methanes, ethanes, propanes, and butanes. Anesth Analg (1994) 1.52
Ethylene--halothane anesthesia: addition or synergism? Anesthesiology (1969) 1.51
Blockade of glutamate receptors and barbiturate anesthesia: increased sensitivity to pentobarbital-induced anesthesia despite reduced inhibition of AMPA receptors in GluR2 null mutant mice. Anesthesiology (1999) 1.51
Naturally occurring variability in anesthetic potency among inbred mouse strains. Anesth Analg (2000) 1.51
Absorption and degradation of sevoflurane and isoflurane in a conventional anesthetic circuit. Anesth Analg (1991) 1.48
Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol (2000) 1.45
Determination of anesthetic requirement in rats. Anesthesiology (1974) 1.43
Specific gravities of desflurane, enflurane, halothane, isoflurane, and sevoflurane. Anesth Analg (1994) 1.43
The degradation, absorption, and solubility of volatile anesthetics in soda lime depend on water content. Anesth Analg (1994) 1.40
Forty-hertz midlatency auditory evoked potential activity predicts wakeful response during desflurane and propofol anesthesia in volunteers. Anesthesiology (1999) 1.39
Cerebral blood flow in man at high altitude. Role of cerebrospinal fluid pH in normalization of flow in chronic hypocapnia. Circ Res (1966) 1.39
Halogenation and anesthetic potency. Anesth Analg (1989) 1.38
Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg (1989) 1.33
A molecular description of how noble gases and nitrogen bind to a model site of anesthetic action. Anesth Analg (1998) 1.31
Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics) Anesth Analg (1998) 1.28
What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg (1991) 1.28
Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia. Mol Pharmacol (1994) 1.28
Blockade of AMPA receptors and volatile anesthetics: reduced anesthetic requirements in GluR2 null mutant mice for loss of the righting reflex and antinociception but not minimum alveolar concentration. Anesthesiology (2001) 1.27
Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth Analg (1987) 1.25
Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages. Anesthesiology (1975) 1.21
Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans. Anesthesiology (1994) 1.18
Cardiovascular effects of carbon dioxide in man. Anesthesiology (1974) 1.17
Effects of isoflurane and nitrous oxide in subanesthetic concentrations on memory and responsiveness in volunteers. Anesthesiology (1992) 1.15
No correlation between quantitative electroencephalographic measurements and movement response to noxious stimuli during isoflurane anesthesia in rats. Anesthesiology (1992) 1.15
The pharmacology of isoflurane. Br J Anaesth (1984) 1.14
The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers. Anesth Analg (1998) 1.14
A demonstration of the concentration and second gas effects in humans anesthetized with nitrous oxide and desflurane. Anesth Analg (1999) 1.13
Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg (1997) 1.13
Mouse strain modestly influences minimum alveolar anesthetic concentration and convulsivity of inhaled compounds. Anesth Analg (1999) 1.12
The effect of age on the rate of increase of alveolar anesthetic concentration. Anesthesiology (1971) 1.12
Narcotic properties of carbon dioxide in the dog. Anesthesiology (1967) 1.09
Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology (1991) 1.09
Equipotent alveolar concentrations of methoxyflurane, halothane, diethyl ether, fluroxene, cyclopropane, xenon and nitrous oxide in the dog. Anesthesiology (1966) 1.07
MAC expanded: AD50 and AD95 values of common inhalation anesthetics in man. Anesthesiology (1975) 1.07
Anesthetic potencies of n-alkanols: results of additivity and solubility studies suggest a mechanism of action similar to that for conventional inhaled anesthetics. Anesth Analg (1997) 1.07
Absorbents differ enormously in their capacity to produce compound A and carbon monoxide. Anesth Analg (2000) 1.06
Rates of awakening from anesthesia with I-653, halothane, isoflurane, and sevoflurane: a test of the effect of anesthetic concentration and duration in rats. Anesth Analg (1987) 1.06
A comparison of the cardiovascular effects of halothane, fluroxene, ether and cyclopropane in man: a resumé. Anesthesiology (1971) 1.05
Minimum alveolar concentrations of methoxyflurane, halothane, ether and cyclopropane in man: correlation with theories of anesthesia. Anesthesiology (1968) 1.05
Partition coefficients of I-653 in human blood, saline, and olive oil. Anesth Analg (1987) 1.04
Influence of CO2 on ventilatory acclimatization to altitude. J Appl Physiol (1968) 1.02
Anesthetic potencies and the unitary theory of narcosis. Anesth Analg (1981) 1.02
Inhaled anesthetic responses of recombinant receptors and knockin mice harboring α2(S270H/L277A) GABA(A) receptor subunits that are resistant to isoflurane. J Pharmacol Exp Ther (2010) 1.01
The cardiovascular effects of a new inhalation anesthetic, Forane, in human volunteers at constant arterial carbon dioxide tension. Anesthesiology (1971) 1.01
The minimum alveolar concentration of nitrous oxide in man. Anesth Analg (1982) 1.01
Comparative times to peak effect and durations of action of neostigmine and pyridostigmine. Anesthesiology (1974) 1.00
Temperature dependence of halothane and cyclopropane anesthesia in dogs: correlation with some theories of anesthetic action. Anesthesiology (1966) 0.99
Fentanyl, esmolol, and clonidine blunt the transient cardiovascular stimulation induced by desflurane in humans. Anesthesiology (1994) 0.99
Etomidate vs. thiopental with and without fentanyl--a comparative study of awakening in man. Anesthesiology (1980) 0.99
Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology (1991) 0.98
The concentration of isoflurane required to suppress learning depends on the type of learning. Anesthesiology (2001) 0.98
Enzyme induction by enflurane in man. Anesthesiology (1976) 0.97
Comparative toxicities of halothane, isoflurane, and diethyl ether at subanesthetic concentrations in laboratory animals. Anesthesiology (1975) 0.97
Nitrous oxide minimum alveolar anesthetic concentration in rats is greater than previously reported. Anesth Analg (1994) 0.97
Naloxone does not antagonize general anesthesia in the rat. Anesthesiology (1978) 0.96
The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption. Anesth Analg (1999) 0.96
A test of the carcinogenicity of enflurane, isoflurane, halothane, methoxyflurane, and nitrous oxide in mice. Anesth Analg (1979) 0.96
Nitrous oxide inactivates methionine synthetase in human liver. Anesth Analg (1982) 0.96
The dependence of pancuronium- and d-tubocurarine-induced neuromuscular blockades on alveolar concentrations of halothane and forane. Anesthesiology (1972) 0.96
The ventilatory effects of Forane, a new inhaled anesthetic. Anesthesiology (1971) 0.95
Behavioral effects of trace and subanesthetic halothane and nitrous oxide in man. Anesthesiology (1978) 0.95
The electroencephalogram in man anesthetized with forane. Anesthesiology (1971) 0.94
Neither GABA(A) nor strychnine-sensitive glycine receptors are the sole mediators of MAC for isoflurane. Anesth Analg (2001) 0.94